Standard Biotools (LAB) Asset Utilization Ratio (2011 - 2026)
Standard Biotools' (LAB) quarterly Asset Utilization Ratio came in at 0.14 in Q1 2026, down 4.9% year-on-year from 0.15 in Q1 2025, and down 7.25% on a QoQ basis from 0.15 in Q4 2025.
Standard Biotools (LAB) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Standard Biotools (LAB) has 16 years of Asset Utilization Ratio data on file, last reported at 0.14 in Q1 2026.
- On a quarterly basis, Asset Utilization Ratio fell 4.9% year-over-year to 0.14 in Q1 2026; TTM through Mar 2026 was 0.14, a 4.9% decrease from a year earlier, with the FY2025 full-year figure at 0.14, down 25.68% from the prior year.
- Asset Utilization Ratio for Q1 2026 stood at 0.14, down from 0.15 in the prior quarter.
- Over the last five years, Asset Utilization Ratio for LAB reached as high as 0.79 in Q1 2022 and fell as low as 0.14 in Q1 2026.
- Historically, Asset Utilization Ratio has averaged 0.27 across 5 years, with a median of 0.23 in 2024.
- Across the five-year window, Asset Utilization Ratio soared 73.06% in 2022 and sank 67.81% in 2023, its largest moves.
- Year by year, Asset Utilization Ratio stood at 0.24 in 2022, then surged by 31.99% to 0.32 in 2023, then slumped by 44.69% to 0.18 in 2024, then retreated by 13.22% to 0.15 in 2025, then fell by 7.25% to 0.14 in 2026.
- Per Business Quant data, the three most recent Asset Utilization Ratio figures were 0.14 in Q1 2026, 0.15 in Q4 2025, and 0.16 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.58 Bn | 176.28 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 129.01 Bn | 126.13 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 68.67 Bn | 67.22 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn | 0.47 |
| 6 | Dexcom | 28.34 Bn | 27.23 Bn | 750.30 Mn | 0.74 |
| 7 | GE HealthCare Technologies | 28.07 Bn | 25.79 Bn | 1.98 Bn | 0.57 |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - | - |
| 9 | Koninklijke Philips | 24.12 Bn | 21.00 Bn | 2.07 Bn | 0.65 |
| 10 | Standard Biotools | 301.83 Mn | -153.35 Mn | 11.31 Mn | 0.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.14 |
| Dec 31, 2025 | 0.15 |
| Sep 30, 2025 | 0.16 |
| Jun 30, 2025 | 0.16 |
| Mar 31, 2025 | 0.15 |
| Dec 31, 2024 | 0.18 |
| Sep 30, 2024 | 0.17 |
| Jun 30, 2024 | 0.16 |
| Mar 31, 2024 | 0.23 |
| Dec 31, 2023 | 0.32 |
| Sep 30, 2023 | 0.30 |
| Jun 30, 2023 | 0.29 |
| Mar 31, 2023 | 0.25 |
| Dec 31, 2022 | 0.24 |
| Sep 30, 2022 | 0.38 |
| Jun 30, 2022 | 0.56 |
| Mar 31, 2022 | 0.79 |
| Sep 30, 2021 | 0.82 |
| Jun 30, 2021 | 0.61 |
| Mar 31, 2021 | 0.46 |